Merck & Co., Inc. (MRK) Insider Trading Activity

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Show less

Over the last 12 months, insiders at Merck & Co., Inc. have bought $0 and sold $32.18M worth of Merck & Co., Inc. stock.

On average, over the past 5 years, insiders at Merck & Co., Inc. have bought $810,918 and sold $105.27M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 2,833 shares for transaction amount of $250,000 was made by THULIN INGE G (director) on 2025‑02‑06.